Selenium News June 11, 2007
Home
Print This Page

Major studies on the benefits of Selenium


Suppression of human immunodefiency virus type 1 viral load with selenium supplementation
Hurwitz BE et al 2007
Archives of Internal Medicine 167:1-8.

Selenium in the immune system
Arthur JR, et al 2003
Journal of Nutrition 133:1457S-1459S.

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin
Clark LC, et al 1996
Journal of the American Medical Association 276(24):1957-1963.

The importance of selenium to human health
Rayman MP, et al 2000
The Lancet 356:233-241.

Nutritional selenium supplements: Product types, quality, and safety
Schrauzer GN 2001
Journal of the American College of Nutrition 20(1):1-4.

Selenomethionine: A review of its nutritional significance, metabolism and toxicity
Schrauzer GN 2000
Journal of Nutrition 130:1653-1656.

An evaluation of the bioavailability of selenium in high-selenium yeast
Yoshida M, et al 1999.
Journal of Nutritional Science and Vitaminology 45, 119-128.

News

"Mineral shows promise on HIV" - LA Times - 1/23/07

"Selenium Supplements Add Punch to HIV Fight" - abcnews.com - 1/23/07

"UM Study Shows Supplement Helps HIV Patients" - NBC Miami - 1/23/07

"Selenium may suppress HIV viral load" - United Press International - 1/23/07

"Selenium Treatment Beneficial in HIV" - aidsmeds.com - 1/23/07

"Dietary Supplement Selenium Reduces HIV Viral Load, Increases CD4+ T Cell Count, Study Says" - kaisernetwork.org - 1/23/07

"Selenium found to lower HIV level" - earthtimes.org - 1/23/07

"Dietary Supplement Selenium Reduces HIV Viral Load, Increases CD4+ T Cell Count, Study Says" - thebody.com - 1/23/07

"Selenium may help lower HIV levels" - Reuters Health - 1/22/07

Contacts

Chad Hyett
Account Supervisor
Fleishman Hillard
212.453.2493

Maryrose Lombardo
Public Relations Manager
Nutrition 21 Inc.
914.701.4525


Background Info


Bookmarks


Graphics


Audio & Video
Audio & Video

This 60-second segment explores study results and Selenomax availability.


In the following video interviews, Dr. Keith Thomas Ayoob, EdD, RD FADA, associate professor of pediatrics, Albert Einstein College of Medicine, New York explains the significance of this study.